When Nanoparticles Rule the World, Treatments Get Better
https://pixabay.com/en/globe-earth-world-globalization-895580/

When Nanoparticles Rule the World, Treatments Get Better

What the heck is a nanoparticle? It sounds very Twilight Zone-ish, and in some ways, nanoparticles are just that. The thing is, nanoparticles are the movers and shakers of the biologic…

Continue Reading When Nanoparticles Rule the World, Treatments Get Better
5 Bloody Amazing Things About the Bleeding Disorder Red Tie Challenge
Source: pixabay.com

5 Bloody Amazing Things About the Bleeding Disorder Red Tie Challenge

Ever heard that blood is thicker than water? Not only am I sure the National Hemophilia Foundation (NHF) has heard it—they’re essentially creating a movement around it. And it’s pretty…

Continue Reading 5 Bloody Amazing Things About the Bleeding Disorder Red Tie Challenge

Why This New CVID Research Is The Most Exciting Thing You’ll Hear About Today

Most researchers like to say that their work is “groundbreaking” or “revolutionary.” And most reporters—whether print or digital—like to use those words too, because they help get people’s attention. But…

Continue Reading Why This New CVID Research Is The Most Exciting Thing You’ll Hear About Today
WTF is IPF… and Now What Do I Do?
https://pixabay.com/en/question-mark-question-symbol-463497/

WTF is IPF… and Now What Do I Do?

I have lost two cousins and a very inspiring friend to idiopathic pulmonary fibrosis (IPF). So I’m very aware that: There’s a genetic component to the disease (if more than…

Continue Reading WTF is IPF… and Now What Do I Do?

VTP-43742 enters Phase I for Ankylosing Spondylitis

Vitae Pharmaceuticals Announces Positive Top-Line Results From Initial Phase 1 Study of First-in-Class RORyt Inhibitor VTP-43742 in Autoimmune Disorders back in September. Vitae Pharmaceuticals, Inc. (“Vitae”)  is developing VTP-43742 for…

Continue Reading VTP-43742 enters Phase I for Ankylosing Spondylitis

Sponsored Research of Pharmacodynamic Biomarkers

Michael J. Fox Foundation Announces New Research Initiative for Pharmacodynamic (PD) Biomarker Like many other diseases such as Lyme disease, there is no current, easily measured bio-marker for Parkinson’s. Without…

Continue Reading Sponsored Research of Pharmacodynamic Biomarkers
Close Menu